Australian MMJ Company Aims to Raise $4M for Human Trials

A publicly traded Australian pharmaceutical and biotech company which recently entered the medical marijuana sector aims to raise about $4.1 million (AUS $5.4 million) to support MMJ trials on human subjects.

If successful, Medlab Clinical plans to spend the money to accelerate a program of human trials of cannabis-based pain management therapy for cancer patients at one of Australia’s top oncology research hospitals, Business Insider Australia reported.

According to Medlab’s filing with the Australian Securities Exchange, the company…

CONTINUE READING: Click Here to Continue Reading Article …